Market Cap 190.98B
Revenue (ttm) 44.33B
Net Income (ttm) 6.52B
EPS (ttm) N/A
PE Ratio 21.15
Forward PE 20.15
Profit Margin 14.72%
Debt to Equity Ratio 0.63
Volume 9,781,700
Avg Vol 12,188,380
Day's Range N/A - N/A
Shares Out 1.73B
Stochastic %K 88%
Beta 0.59
Analysts Strong Sell
Price Target $120.41

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, United States
DidYouReadThis
DidYouReadThis Aug. 18 at 8:24 PM
$ABT nice chart
0 · Reply
DBRGLong
DBRGLong Aug. 18 at 3:00 PM
$ABT happy belated dividend day to all (from yesterday...) - going to keep reinvesting mine & let it continue to add more shares & compound, as we grind our way to 160+ in the coming years 🥂
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 15 at 5:34 PM
$ABT Abbott Laboratories (NYSE: ABT) is gaining attention with FreeStyle Libre, diagnostics, nutrition and cancer screening exposure. Here’s why ABT stock could have more room to run. https://biotechhealthx.com/biotech-news/what-makes-abbott-laboratories-abt-a-smart-buy-and-hold-investment/
0 · Reply
jedrzejjj10
jedrzejjj10 Aug. 14 at 6:45 AM
$ABT That was it. Easy one
0 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:25 AM
1 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:13 AM
$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB
0 · Reply
parcha
parcha Aug. 14 at 12:21 AM
Jim Cramer's top 10 things to watch in the stock market Thursday $ABT A lot of love for Abbott. Wolfe Research upgraded the stock to buy from hold, pointing to organic growth improvements and a potential re-rating of shares. Citi raised its price target to $125 from $112. Analysts are more upbeat on medtech after earnings. 2027 estimates for the group seem to be at more reasonable levels. We thankfully exited Abbott last fall, avoiding what had been a rough 2026. Johnson & Johnson gives us medtech exposure now. Need it lower before we buy any more. https://www.cnbc.com/2026/08/13/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Oldpuck
Oldpuck Aug. 13 at 5:37 PM
$ABT pretty sure dividend payments are tomorrow
1 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 13 at 5:37 PM
$ABT Come down to 105 so I can close my hedge.
0 · Reply
1212JM
1212JM Aug. 13 at 2:44 PM
$ABT this thing has traded sideways and consolidated for 5 years straight, despite beating guidance multiple times and revenue and profit growth. Will be trading at $200 as soon as Exact sciences dilution falls off in early 2027.
0 · Reply
Latest News on ABT
Abbott Laboratories Earnings Call Transcript: Q2 2026

Jul 16, 2026, 9:00 AM EDT - 4 weeks ago

Abbott Laboratories Earnings Call Transcript: Q2 2026


Abbott Laboratories Earnings release: Q2 2026

Jul 16, 2026, 9:00 AM EDT - 4 weeks ago

Abbott Laboratories Earnings release: Q2 2026


Abbott Laboratories Slides: Q2 2026

Jul 16, 2026, 9:00 AM EDT - 4 weeks ago

Abbott Laboratories Slides: Q2 2026


Abbott Laboratories Quarterly report: Q2 2026

Jul 16, 2026, 9:00 AM EDT - 4 weeks ago

Abbott Laboratories Quarterly report: Q2 2026


Abbott Laboratories Sales Rise on Diagnostics Growth

Jul 16, 2026, 8:08 AM EDT - 4 weeks ago

Abbott Laboratories Sales Rise on Diagnostics Growth

ABT


Abbott raises 2026 profit forecast on heart device strength

Jul 16, 2026, 7:33 AM EDT - 4 weeks ago

Abbott raises 2026 profit forecast on heart device strength

ABT


Abbott hosts conference call for second-quarter earnings

Jun 25, 2026, 9:00 AM EDT - 7 weeks ago

Abbott hosts conference call for second-quarter earnings

ABT


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Abbott declares 410th consecutive quarterly dividend

Jun 12, 2026, 2:29 PM EDT - 2 months ago

Abbott declares 410th consecutive quarterly dividend

ABT


Abbott Laboratories Earnings Call Transcript: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Abbott Laboratories Earnings Call Transcript: Q1 2026


Abbott Laboratories Earnings release: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Abbott Laboratories Earnings release: Q1 2026


Abbott Laboratories Slides: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Abbott Laboratories Slides: Q1 2026


Abbott Laboratories Quarterly report: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 4 months ago

Abbott Laboratories Quarterly report: Q1 2026


Abbott hosts conference call for first-quarter earnings

Mar 26, 2026, 9:00 AM EDT - 5 months ago

Abbott hosts conference call for first-quarter earnings

ABT


Abbott completes acquisition of Exact Sciences

Mar 23, 2026, 8:50 AM EDT - 5 months ago

Abbott completes acquisition of Exact Sciences

ABT


Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Abbott Laboratories Proxy statement: Proxy Filing


Abbott Laboratories Proxy statement: Proxy Filing

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Abbott Laboratories Proxy statement: Proxy Filing


Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 6 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

ABT EXAS


Abbott declares 409th consecutive quarterly dividend

Feb 20, 2026, 11:38 AM EST - 6 months ago

Abbott declares 409th consecutive quarterly dividend

ABT


DidYouReadThis
DidYouReadThis Aug. 18 at 8:24 PM
$ABT nice chart
0 · Reply
DBRGLong
DBRGLong Aug. 18 at 3:00 PM
$ABT happy belated dividend day to all (from yesterday...) - going to keep reinvesting mine & let it continue to add more shares & compound, as we grind our way to 160+ in the coming years 🥂
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 15 at 5:34 PM
$ABT Abbott Laboratories (NYSE: ABT) is gaining attention with FreeStyle Libre, diagnostics, nutrition and cancer screening exposure. Here’s why ABT stock could have more room to run. https://biotechhealthx.com/biotech-news/what-makes-abbott-laboratories-abt-a-smart-buy-and-hold-investment/
0 · Reply
jedrzejjj10
jedrzejjj10 Aug. 14 at 6:45 AM
$ABT That was it. Easy one
0 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:25 AM
1 · Reply
JInvestTrade
JInvestTrade Aug. 14 at 1:13 AM
$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB
0 · Reply
parcha
parcha Aug. 14 at 12:21 AM
Jim Cramer's top 10 things to watch in the stock market Thursday $ABT A lot of love for Abbott. Wolfe Research upgraded the stock to buy from hold, pointing to organic growth improvements and a potential re-rating of shares. Citi raised its price target to $125 from $112. Analysts are more upbeat on medtech after earnings. 2027 estimates for the group seem to be at more reasonable levels. We thankfully exited Abbott last fall, avoiding what had been a rough 2026. Johnson & Johnson gives us medtech exposure now. Need it lower before we buy any more. https://www.cnbc.com/2026/08/13/jim-cramers-top-10-things-to-watch-in-the-stock-market-thursday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Oldpuck
Oldpuck Aug. 13 at 5:37 PM
$ABT pretty sure dividend payments are tomorrow
1 · Reply
EmbraceVolatility
EmbraceVolatility Aug. 13 at 5:37 PM
$ABT Come down to 105 so I can close my hedge.
0 · Reply
1212JM
1212JM Aug. 13 at 2:44 PM
$ABT this thing has traded sideways and consolidated for 5 years straight, despite beating guidance multiple times and revenue and profit growth. Will be trading at $200 as soon as Exact sciences dilution falls off in early 2027.
0 · Reply
DBRGLong
DBRGLong Aug. 13 at 2:42 PM
$ABT higher highs & higher lows. $120+ is in play for us in the coming weeks, & we can't discount the possibility of $130+ by year-end, pending the outcome with the next round of earnings that will be reported in November. 🥂
0 · Reply
Estimize
Estimize Aug. 13 at 1:48 PM
Wall St is expecting 1.42 EPS for $ABT Q3 [Reporting 10/21 BMO] http://www.estimize.com/intro/abt?chart=historical&metric_name=eps&utm_cont
0 · Reply
TheStockTraderHub
TheStockTraderHub Aug. 13 at 1:09 PM
Thursday’s biggest analyst calls: Citi reiterates SpaceX as buy Bank of America reiterates MongoDB as buy Wolfe upgrades AbbVie to outperform from peer perform Wolfe upgrades Abbott Labs to outperform from peer perform JPMorgan resumes Salesforce at overweight $SPX $MDB $ABBV $ABT $CRM
0 · Reply
londoneast
londoneast Aug. 12 at 4:53 PM
$SENS Part 1: An interesting perspective from a diabetes industry veteran! I recently exchanged views with David Kliff, who has followed the diabetes industry for more than 30 years. Despite the encouraging Q2 numbers from Senseonics, he remains convinced that $SENS will never become a serious threat to $DXCM or $ABT. Why? 👇
0 · Reply
OnlyFibs
OnlyFibs Aug. 11 at 11:40 PM
Abbott Laboratories $ABT (8h) Bullish Flow: Direct opening sweeps are repeatedly hitting October $110 Calls (2,764 OI), aggressively absorbing ask liquidity as spot price trends higher near $108.80. Institutional buyers are treating the post-earnings breakout as prime accumulation vehicle gross margins expand 100 bps to 58% and $2.1B in quarterly capital returnconfirms elite balance sheet execution. 🐂 💧 Bull Key Level: $114.80 (Bull confirmation to clear primary upper wick friction and unlock explosive trend expansion) 🐂 🔥 Bear Key Level: $93.50 (Absolute structural breakdown defense level and lower volume shelf) 🐻 ⚠️ Targets: $122.00 / $130.00 💰 🍺 Why: Price action has cleared its primary 8-hour moving average ribbon and turned sharply higher with expanding green volume bars. The RSI indicator is holding firmly above 60 out of oversold territory, signaling buyers maintain complete structural control over the baseline. #abt | #hovdid
0 · Reply
NRG8
NRG8 Aug. 11 at 3:09 PM
0 · Reply
1212JM
1212JM Aug. 11 at 1:15 PM
$ABT $GOOGL partnership with AI and Glucose data to give people health insights
1 · Reply
pnvoss
pnvoss Aug. 10 at 2:29 AM
$BSX what if Bsx $JNJ or $ABT merged or bought out bsx?
2 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 9 at 4:27 PM
$SENS $DXCM $ABT Remember when we called the play years ago? This one alone deserves a “follow”.
0 · Reply
Enjoy_Life_Bro
Enjoy_Life_Bro Aug. 9 at 3:27 AM
$ABT Should be back at $130
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 9 at 2:47 AM
$GILD $ABT $DHR $LLY $MRK Analysts see meaningful upside in several top healthcare stocks for 2026, with one biotech leader offering nearly 30% implied upside based on the analyst target and supplied market price. https://biotechhealthx.com/biotech-news/top-5-healthcare-stocks-to-buy-with-1000-in-2026/
0 · Reply
Broview
Broview Aug. 8 at 4:53 PM
$ABT will up trend last?
0 · Reply